Skip to main content
BCSF logo

BCSF · Bain Capital Specialty Finance, Inc.

Track BCSF — free
$10.37 -0.07 (-0.67%) At close · Nov 20
Market Cap
$672.69M
Shares
64.87M
Volume · Nov 20 585.65K Avg daily vol (3M) 527.44K

Price & Indicators

 

Key stats

Close
$10.37
Fri 20 Nov
Open
$10.37
Fri 20 Nov
Average volume, 30 days
538K
shares a session
Short interest
1.2M
1.8% of shares · 2.2 days to cover
Day range
$10.35$10.53
Open $10.37 Close $10.37
52-week closing range
$10.05$14.60
Close $10.37 29.0% under the high
Short volume, last session
64%
Last earnings
Nov 10, 2026
Latest filing
10-Q · Nov 9
Price history
Jan 2020 to Nov 2026

Up next

Feb 26, 2027 Est · unconfirmed · in 14 wks

Latest documents

2026
Nov 10
Earnings call
Regular dividend maintained with 102% earnings coverage

Bain Capital Specialty Finance maintained its $0.42 per share regular dividend as Q3 net investment income of $0.43 per share, a 10.3% annualized yield on equity, covered it by 102%; nonaccruals held at 2.2% of portfolio fair value.

3 source passages
Hello, everyone. Welcome to today's Bain Capital Specialty Finance third quarter ended September 30th, 2026 earnings conference call. Net investment income per share was $0.43, representing an annualized yield of 10.3% on equity, covering our regular dividend of $0.42 per share by 102%. Non-accruals were stable quarter over quarter at 2.2% of the portfolio at fair value and 3.3% at amortized cost. Open the document at this passage
Nov 9
Current report 8-K Events of Nov 4
$0.42 per share dividend declared for fourth quarter 2026

Bain Capital Specialty Finance, Inc. declared a fourth fiscal quarter 2026 dividend of $0.42 per share, payable no later than December 29, 2026 to stockholders of record as of December 15, 2026.

Financial results, Director or officer change, or executive pay, Charter or bylaw amendment, or fiscal year change, Other events Read from the first part of this long document
Source passage
On November 9, 2026, the Company issued a press release announcing the declaration of a fourth fiscal quarter 2026 dividend of $0.42 per share. The fourth fiscal quarter 2026 dividend of $0.42 per share is for stockholders of record as of December 15, 2026 and payable no later than the close of business on December 29, 2026. Open the document at this passage
Nov 9
Quarterly report 10-Q FY2026 Q3, ended Sep 30
Quarterly investment activity produced net portfolio contraction

Bain Capital Specialty Finance, Inc. invested $121.5 million across 120 portfolio companies and reported a net decrease in investments of $81.6 million for the three months ended September 30, 2026.

Net income $16.71M ▼ 10.7% Diluted EPS $0.26 ▼ 10.3%
Read from the MD&A section
2 source passages
Bain Capital Specialty Finance, Inc. (the “Company”, “we”, “our” and “us”) is an externally managed specialty finance company focused on lending to middle market companies. During the three months ended September 30, 2026, we invested $121.5 million, including PIK, in 120 portfolio companies, and had $203.1 million in aggregate amount of principal repayments and sales, resulting in a net decrease in investments of $81.6 million for the period. Open the document at this passage
Oct 27
Current report 8-K Events of Oct 26
Bain Capital Specialty Finance to report Q3 2026 results November 9

Bain Capital Specialty Finance, Inc. will release its financial results for the quarter ended September 30, 2026 on Monday, November 9, 2026 after market close. Management will host a conference call on Tuesday, November 10, 2026 at 10:00 a.m. Eastern Time to discuss the results.

Financial results
2 source passages
will report its financial results for the third quarter ended September 30, 2026 on Monday, November 9, 2026 after market close Management will host a conference call on Tuesday, November 10, 2026 at 10:00 a.m. Eastern Time to discuss the Company’s financial results. Open the document at this passage
All documents

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$256.61M
Trailing 12 months
Net income (TTM)
$61.94M
Trailing 12 months
Revenue growth YoY
-10.9%
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
10.8
Trailing earnings · reciprocal yield 9.3%
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
−$1.27B
Latest balance sheet
Dividend yield
17.9%
Trailing 12 months
Shares change YoY
+0.0%
Year over year
Price change (1Y)
-24.7%
Trailing year
Short interest
1.8%
Latest settlement · 2.2 days to cover
View all 125 metrics

AI Brief

Q3 FY26 earnings call · Nov 10, 2026
Q3 FY26

TL;DR. Q3 net investment income of $0.43 per share covered the regular dividend of $0.42 per share by 102%, credit quality remained healthy with stable nonaccruals, quarter-end liquidity was strong at $962 million, and portfolio yields rose to 11.2% at amortized cost. The main negatives were lower net investment income, net realized and unrealized losses, weak industry deal activity, a larger watchlist, soft ISLP returns, and dividend uncertainty as funding costs reset to higher rates.

Bullish
  • + Net investment income was $0.43 per share, an annualized 10.3% yield on equity that covered the regular dividend by 102%.
  • + Credit quality remained healthy and nonaccruals were stable at 2.2% of portfolio fair value.
  • + The regular dividend was maintained at $0.42 per share for the fourth quarter, equating to a 10.2% annualized yield on ending Q3 book value.
  • + Quarter-end liquidity was strong at $962 million, including $887 million of undrawn revolving credit facility capacity.
  • + Portfolio yields increased to 11.2% at amortized cost and 10.7% at fair value.
  • + The portfolio is positioned to benefit from higher rates, with a stated sensitivity of approximately $0.01 per share of quarterly earnings for each 100-basis-point base-rate increase.
Bearish
  • − Net investment income declined to $27.7 million, or $0.43 per share, from $28.6 million, or $0.44 per share.
  • − The company recorded net realized and unrealized losses of $11 million, or $0.17 per share, for the quarter.
  • − Industry deal activity remained weak, and the company deliberately reduced its pace of new originations.
  • − Investments rated 3 or 4 increased to 7.4% of portfolio fair value from 5.8% in the prior quarter because of healthcare-company softness.
  • − ISLP's trailing four-quarter return on equity was 9%, modestly below the low-double-digit target.
  • − The board is evaluating the dividend against a higher-rate funding environment than in 2027.

AI-generated from the earnings call and 8-K · may contain errors · not investment advice

Equibles Rating

blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical Strong Sell Momentum Weak Sentiment Bullish Fundamentals Fair Quant / Vol Low
Market backdrop VIX 35.9 · fear Equity put/call 0.77
Technical
price trend
Strong Sell
50 / 200-day cross No cross
Price vs 200-day avg −16%
below
Price vs 50-day avg −4%
below
RSI (14) 38
neutral
MACD trend Negative
52-week position 7%
near low
Volume (OBV) Bearish div.
distributing
Momentum
relative strength
Weak
1-month return +3%
trailing
6-month return −22%
trailing
YTD return −25%
this year
Relative strength −13%
vs S&P · 6-mo
Sentiment
smart money
Bullish
Trend (MA cross) No cross
50d $11 › 200d $12 — 200d above 50d
Institutional flow Accumulating
+2% holders QoQ · +19 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
1.85% of shares out · ▼ -12.3% MoM · 2.2 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
134 holders — mid 3-yr range
Squeeze score 46
elevated · 0–100
Fundamentals
Fair
EPS growth −17%
Y/Y
Valuation P/E 10.8
below peers
Buyback $50.0M
authorized
Balance sheet $1.4B
net debt
Quant / Vol
risk profile
Low
Volatility 24%
annualized · 1-yr
Max drawdown −31%
past year
ATR 2.7%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Latest guidance · from the Earnings Call filed Nov 10, 2026
Fourth quarter dividend · fourth quarter $0.42

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Strong Sell
4 · 3 · 0
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−16% Bearish
Price vs 50-day avg
−4% Neutral
RSI (14)
38 Neutral
MACD trend
Negative Bearish
52-week position
7% Bearish
Volume (OBV)
Bearish div. Bearish
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross) No cross
50d $11 › 200d $12 — 200d above 50d
Institutional flow Accumulating
+2% holders QoQ · +19 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
1.85% of shares out · ▼ -12.3% MoM · 2.2 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
134 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $10 Now $10 · 7% Range high $15
vs 200-day avg -16% vs 50-day avg -4%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings
Metric Latest Period YoY
Aggregate principal amount of debt and equity investments invested since commencing investment o $10.24B Since October 13, 2016, through September 30, 2026 —
Average notional exposure for interest rate swaps $700M the three months ended September 30, 2026 filing —
Average U.S. dollar notional exposure to forward currency exchange contracts $206.9M the three months ended September 30, 2026 filing —
Capacity under Sumitomo Credit Facility $887M As of September 30, 2026 —
Floating rate debt investments (% of debt investments at fair value) 94.1% As of September 30, 2026 —
Invested, including PIK $121.5M the three months ended September 30, 2026 filing —
Investment fundings $121.5M three months ended September 30, 2026 —
Investment portfolio fair value $2.27B As of September 30, 2026 —
Investments on non-accrual (% of total investment portfolio at amortized cost) 3.3% As of September 30, 2026 —
Investments on non-accrual (% of total investment portfolio at fair value) 2.2% As of September 30, 2026 —
Net asset value per share $16.49 As of September 30, 2026 —
Portfolio companies (count) 215 As of September 30, 2026 —
Sales and Repayments $203.1M Q3 2026 —
Undrawn investment commitments $435.5M As of September 30, 2026 —
Weighted average yield on investment portfolio at amortized cost 11.2% As of September 30, 2026 —
Weighted average yield on investment portfolio at fair value 10.7% As of September 30, 2026 —
Per share net increase in net assets resulting from operations $0.22 the three months ended June 30, 2026 filing —

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Asset Management — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
BCSF
Bain Capital Specialty Finance, Inc.
this stock
$672.69M -25.4% — 10.8 1.8%
BLK
BlackRock, Inc.
$178.51B +2.9% +16.2% 25.1 1.3%
BN
BROOKFIELD Corp
$84.03B -17.7% — — 1.0%
BX
Blackstone Inc.
$83.22B -28.1% +9.2% 24.7 2.6%
KKR
KKR & Co. Inc.
$78.99B -30.5% -11.0% — 1.6%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
134
% held
57.6%
Net QoQ
+641.0K sh
Top holder
Bain Capital Credit, LP
Held Float
View
Held by Funds
Fund positions
8
View
Short & Settlement
Short Interest Falling
Shares short
1.2M
Days to cover
2.2d
Change
-168.5K sh
View
Short Volume
Short vol %
64%
As of
Nov 20, 2026
Short Total
View
Fails to Deliver
FTD shares
5.0K
Value
$52.9K
As of
Oct 29, 2026
View
Off-Exchange
Off-exchange %
38.1%
Week of
Oct 12, 2026
Off-exch Lit
View
Financials
Financials
Net income (FY)
$98.8M
EPS diluted
$1.53
View
Buybacks
Authorized
$50.0M
View
Filings
SEC Filings
Latest
10-Q
Filed
Nov 9, 2026
This year
17

Bain Capital Specialty Finance, Inc. invested $121.5 million across 120 portfolio companies and reported a net decrease in investments of $81.6 million for the three months ended September 30, 2026.

View
Exempt Offerings
Offering
$150.0M
Filed
Jun 24, 2020
View
Earnings & Events
Webcasts
Last webcast
Nov 10, 2026
View
Investor Relations
Latest news
Bain Capital Specialty Finance Ap…
Published
Nov 9, 2026
View

Performance

5D 20D 120D MTD YTD
BCSF -6.3% +3.0% -22.3% -3.7% -25.5%
SPY -8.6% -9.2% -9.2% -8.7% +1.2%
vs SPY +2.2% +12.2% -13.1% +5.0% -26.6%

Capital returns

Latest dividend
$0.42 / share · ex Sep 15, 2026
Declared · upcoming
$0.42 / share · ex Dec 15, 2026
Raised 180%
Paid (TTM)
$1.86 / share · 5 payouts
Dividend yield (TTM, derived)
17.94%
Full dividend history
Buyback program · as of May 7, 2019
Authorized
$50.00M
Spent (derived)
—
Remaining
—

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 1655050 CUSIP 05684B107 13F (30d) 127 filings 112 filers Visit website Investor relations